Cargando…
Drug Repositioning with GraphSAGE and Clustering Constraints Based on Drug and Disease Networks
The understanding of therapeutic properties is important in drug repositioning and drug discovery. However, chemical or clinical trials are expensive and inefficient to characterize the therapeutic properties of drugs. Recently, artificial intelligence (AI)-assisted algorithms have received extensiv...
Autores principales: | Zhang, Yuchen, Lei, Xiujuan, Pan, Yi, Wu, Fang-Xiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127467/ https://www.ncbi.nlm.nih.gov/pubmed/35620297 http://dx.doi.org/10.3389/fphar.2022.872785 |
Ejemplares similares
-
Drug repositioning based on heterogeneous networks and variational graph autoencoders
por: Lei, Song, et al.
Publicado: (2022) -
Automatic disease prediction from human gut metagenomic data using boosting GraphSAGE
por: Syama, K., et al.
Publicado: (2023) -
Correction: Automatic disease prediction from human gut metagenomic data using boosting GraphSAGE
por: Syama, K., et al.
Publicado: (2023) -
Drug repositioning: A bibliometric analysis
por: Sun, Guojun, et al.
Publicado: (2022) -
Overcoming Obstacles to Drug Repositioning in Japan
por: Nishimura, Yuhei, et al.
Publicado: (2017)